A detailed history of Dafna Capital Management LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Dafna Capital Management LLC holds 189,117 shares of VKTX stock, worth $12.5 Million. This represents 2.57% of its overall portfolio holdings.

Number of Shares
189,117
Previous 194,117 2.58%
Holding current value
$12.5 Million
Previous $15.9 Million 37.02%
% of portfolio
2.57%
Previous 3.83%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$47.39 - $80.2 $236,950 - $401,000
-5,000 Reduced 2.58%
189,117 $10 Million
Q1 2024

May 15, 2024

SELL
$17.4 - $94.5 $941,339 - $5.11 Million
-54,100 Reduced 21.8%
194,117 $15.9 Million
Q4 2023

Feb 14, 2024

SELL
$9.24 - $19.64 $660,087 - $1.4 Million
-71,438 Reduced 22.35%
248,217 $4.62 Million
Q3 2023

Nov 14, 2023

BUY
$10.92 - $16.0 $283,920 - $416,000
26,000 Added 8.85%
319,655 $3.54 Million
Q2 2023

Aug 14, 2023

SELL
$14.84 - $24.79 $378,420 - $632,145
-25,500 Reduced 7.99%
293,655 $4.76 Million
Q1 2023

May 15, 2023

SELL
$8.08 - $17.33 $1.64 Million - $3.51 Million
-202,398 Reduced 38.81%
319,155 $5.31 Million
Q4 2022

Feb 14, 2023

SELL
$2.72 - $9.4 $83,903 - $289,961
-30,847 Reduced 5.58%
521,553 $4.9 Million
Q3 2022

Nov 14, 2022

BUY
$2.55 - $3.89 $229,499 - $350,100
90,000 Added 19.46%
552,400 $1.5 Million
Q2 2022

Aug 15, 2022

BUY
$2.11 - $3.15 $31,649 - $47,250
15,000 Added 3.35%
462,400 $1.34 Million
Q1 2021

May 17, 2021

SELL
$5.74 - $9.67 $48,790 - $82,195
-8,500 Reduced 1.86%
447,400 $2.83 Million
Q4 2020

Feb 16, 2021

BUY
$5.3 - $6.71 $26,500 - $33,550
5,000 Added 1.11%
455,900 $2.57 Million
Q1 2020

May 15, 2020

BUY
$3.45 - $7.95 $833,865 - $1.92 Million
241,700 Added 115.54%
450,900 $2.11 Million
Q2 2019

Aug 14, 2019

BUY
$7.67 - $10.63 $230,100 - $318,900
30,000 Added 16.74%
209,200 $1.74 Million
Q4 2018

Feb 14, 2019

BUY
$7.16 - $16.21 $1.28 Million - $2.9 Million
179,200 New
179,200 $1.37 Million

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $5.05B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Dafna Capital Management LLC Portfolio

Follow Dafna Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.